CAW
HALO icon

Cornerstone Advisors (Washington)’s Halozyme HALO Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-214
Closed -$4K – 1069
2019
Q2 		$4K Buy
+214
New +$3.45K ﹤0.01% 963

Other funds holding HALO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Cornerstone Advisors (Washington)'s HALO Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Halozyme (HALO) in Q3 2019, closing a stake of 214 shares — an estimated $4K sold.

Cornerstone Advisors (Washington) first reported a position in HALO in Q2 2019 and held it in 1 quarter. The position peaked at $4K in Q2 2019. 210 funds tracked by Wall St. Rank hold HALO as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Halozyme position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 214 Halozyme shares in Q3 2019, an estimated $4K.
  • Cornerstone Advisors (Washington) first reported a position in Halozyme in Q2 2019 and held it in 1 quarter.
  • Cornerstone Advisors (Washington)'s Halozyme position peaked at $4K in Q2 2019.
  • 210 funds tracked by Wall St. Rank held Halozyme as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.